Mycophenolate mofetil for severe childhood atopic dermatitis: Experience in 14 patients

British Journal of Dermatology

Volumn 157, Issue 1, 2007, Pages 127-132

  Heller, M ^a   Shin, H T ^a,b   Orlow, S J ^a   Schaffer, J V ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atopic dermatitis; Mycophenolate mofetil

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFDINIR; CETIRIZINE; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; CYPROHEPTADINE; DIPHENHYDRAMINE; DOXEPIN; DOXYCYCLINE; ERYTHROMYCIN; FEXOFENADINE; HYDROXYZINE; LEVOFLOXACIN; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PSORALEN; RIFAMPICIN; VALACICLOVIR;

ADD ON THERAPY; ADJUVANT THERAPY; ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ATOPIC DERMATITIS; BRAIN PSEUDOTUMOR; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLICULITIS; FURUNCULOSIS; GASTROINTESTINAL SYMPTOM; HERPES SIMPLEX; HUMAN; HYPERTENSION; INFECTION; LEUKOPENIA; MALE; MONOTHERAPY; OPTIMAL DRUG DOSE; PHOTOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; SUPERINFECTION; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; NEW YORK; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34250652009     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07947.x     Document Type: Article

References (35)

1. Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin N Am 2006 90 : 149 67.
2. Carroll CL, Balkrishnam R, Feldman SR et al. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005 22 : 192 9.
3. Akhavan A, Rudikoff D. The treatment of atopic dermatitis with systemic immunosuppressive agents. Clin Dermatol 2003 21 : 225 40.
4. Ellis C, Luger T. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003 148 (Suppl. 63 3 10.
5. Hanifin JM, Cooper KD, Ho VC et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol 2004 50 : 391 404.
6. Eichenfield LF, Hanifin JM, Luger TA. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 2003 49 : 1088 9.
7. Dadlani C, Orlow SJ. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol 2005 52 : 316 40.
8. Murphy LA, Atherton D. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression. Br J Dermatol 2002 147 : 308 15.
9. Berth-Jones J, Takwale A, Tan E et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002 147 : 324 30.
10. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006 367 : 839 46.
11. Ettenger R, Sarwal MM. Mycophenolate mofetil in pediatric renal transplantation. Transplantation 2005 80 (Suppl. 2 S201 10.
12. Filler G, Hansen M, LeBlanc C et al. Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 2003 18 : 445 9.
13. Buratti S, Szer IS, Spencer CH et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 2001 28 : 2103 8.
14. Mendizábal S, Zamora I, Berbel O et al. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 2005 20 : 914 19.
15. Thorne JE, Jabs DA, Qazi FA et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005 112 : 1472 7.
16. Mimouni D, Anhalt GJ, Cummins DL et al. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol 2003 139 : 739 42.
17. Farley-Li J, Mancini AJ. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol 2003 139 : 1121 4.
18. Tran MM, Anhalt GJ, Barrett T et al. Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid- sparing agent. J Am Acad Dermatol 2006 54 : 734 6.
19. Nousari HC, Sragovich A, Kimyai-Asadi A et al. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 1999 40 : 265 8.
20. Hartmann M, Erik A. Mycophenolate mofetil and skin diseases. Lupus 2005 14 (Suppl. 1 S58 63.
21. Benez A, Fierlbeck G. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil. Br J Dermatol 2001 14 : 638 9.
22. Grundmann-Kollmann M, Podda M, Ochsendorf F et al. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol 2001 137 : 870 3.
23. Grundmann-Kollmann M, Korting HC, Behrens S et al. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol 1999 141 : 175 6.
24. Neuber K, Schwartz I, Itschert G et al. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol 2000 143 : 385 91.
25. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980 92 (Suppl. S44 7.
26. Hansen ER, Buus S, Deleuran M et al. Treatment of atopic dermatitis with mycophenolate mofetil. Br J Dermatol 2000 143 : 1324 6.
27. Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf 2001 24 : 645 63.
28. Hantash B, Fiorentino D. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. Arch Dermatol 2006 142 : 109 10.
29. Balal M, Demir E, Paydas S et al. Uncommon side effect of MMF in renal transplant recipients. Ren Fail 2005 27 : 591 4.
30. CellCept [package insert]. Nutley, NJ : Roche Laboratories Inc, 2005.
31. Dharnidharka VR, Ho PL, Stablein DM et al. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002 6 : 396 9.
32. Satchell AC, Barnetson RS. Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate. Br J Dermatol 2000 143 : 202 3.
33. Filler G, Lepage N. To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription. Pediatr Nephrol 2004 19 : 962 5.
34. Filler G, Foster J, Berard R et al. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Transplant Proc 2004 36 : 1327 31.
35. Grundmann-Kollmann M, Kaufmann R, Zollner TM. Treatment of atopic dermatitis with mycophenolate mofetil. Br J Dermatol 2001 145 : 351 2.